MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway

MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma

(2019) Lili Song et al.   BIOMEDICINE & PHARMACOTHERAPY

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

(2019) Rui Chen et al.   Molecular Therapy-Nucleic Acids

MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma

(2018) Dan Wang et al.   BIOSCIENCE REPORTS

MicroRNAs as markers of progression in cervical cancer: a systematic review

(2018) Barbara Pardini et al.   BMC CANCER

MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers

(2018) Chundi Gao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression

(2018) Erle Dang et al.   Cell Death & Disease

Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis

(2018) An Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries

(2017) Lynette Denny et al.   LANCET

Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer

(2016) Haiyan Zhu et al.   TUMOR BIOLOGY

Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer

(2015) H Kang et al.   CELL DEATH AND DIFFERENTIATION

Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82

(2015) Qing-Hui Zhang et al.   DIGESTIVE DISEASES AND SCIENCES

Adenovirus encoding Smad4 suppresses glioma cell proliferation and increases apoptosis through cell cycle arrest at G1 phase

(2015) Zhao Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

BAP31, a promising target for the immunotherapy of malignant melanomas

(2015) Shaojuan Yu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells

(2015) XIAOWEN ZOU et al.   Molecular Medicine Reports

Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2

(2014) Ling Lin et al.   CARCINOGENESIS

TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis

(2014) D. R. Principe et al.   JNCI-Journal of the National Cancer Institute

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer

(2013) Lise Lotte Christensen et al.   INTERNATIONAL JOURNAL OF CANCER

First microRNA mimic enters clinic

(2013) Aaron Bouchie   NATURE BIOTECHNOLOGY

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

(2012) I. A. Babar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chemical modification and design of anti-miRNA oligonucleotides

(2011) K A Lennox et al.   GENE THERAPY

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis

(2011) Takeshi Imamura et al.   Breast Cancer

Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer

(2010) Hye Jung Baek et al.   HEPATOLOGY

Epigenetic Silencing of β-Spectrin, a TGF-β Signaling/Scaffolding Protein in a Human Cancer Stem Cell Disorder

(2010) Zhi-Xing Yao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The dynamic roles of TGF-β in cancer

(2010) Erik Meulmeester et al.   JOURNAL OF PATHOLOGY